Business
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA® for Malaria Prevention
Partnership adds a travel-focused consumer telehealth platform to the ARAKODA® marketing strategy, offering a new convenience to people planning travel to malaria-endemic regions of the worldARAKODA is the only FDA-approved, broad spectrum, once-weekly malaria prevention option for international travelers WASHINGTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new m
About this update from 60 Degrees Pharmaceuticals, Inc.
[{"type":"image","alt":"Sixty Degrees Pharmaceuticals","displaySize":"","headline":null,"caption":"Sixty Degrees Pharmaceuticals","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":157,"url":"https://media.zenfs.com/en/globenewswire.com/6c5f734cbdeffb0ff816df4f768b5fa6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/L1lrb.zKykt_bMbAkYncaQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/6c5f734cbdeffb0ff816df4f768b5fa6","width":300,"height":157}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Partnership adds a travel-focused consumer telehealth platform to the ARAKODA® marketing strategy, offering a new convenience to people planning travel to malaria-endemic regions of the world","length":191,"tagName":"p"}]},{"val":[{"type":"text","content":"ARAKODA is the only FDA-approved, broad spectrum, once-weekly malaria prevention option for international travelers","length":115,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":306,"olType":false},{"type":"text","content":"WASHINGTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced a partnership with Runway Health to expand pre-departure access to ARAKODA® (tafenoquine) for prevention of malaria among international travelers through the Runway Health travel medicine platform.","length":446,"tagName":"p"},{"type":"text","content":"ARAKODA is the only broad spectrum, once-weekly prescription malaria prevention on the U.S. market.","length":99,"tagName":"p"},{"type":"text","content":"Runway Health is a direct-to-patient telehealth platform that enables adults to access physician-led online consultations before traveling to regions of the world where certain illnesses, including malaria, may be prevalent. If prescribed, seamless home delivery of medication arrives before departure.","length":302,"tagName":"p"},{"type":"text","content":"Malaria, which is caused by the bite of the Anopheles mosquito, is one of the most serious, life-threatening infectious diseases in the world. It is a constant threat to those living in malaria-endemic regions and to international travelers to those areas. If left untreated, it ...